ISAP Researchers' Profiles

Cheryl Teruya, Ph.D.

Cheryl Teruya, Ph.D., is currently Co-Principal Investigator of a NIDA-funded study entitled, "Treatment Motivation in Drug Users," and Project Director on three other NIDA-funded studies, including "Homeless Women: Drugs, Race/Ethnicity, and Healthcare," "Treatment System Impact and Outcomes of Proposition 36 in 5 California Counties," and "Readiness for Implementation of Research to Practice," at the UCLA Integrated Substance Abuse Programs. She received her M.A. and her doctorate, both from UCLA and in education (higher education and organizational change division). She conducted her doctoral dissertation on research collaboration within the context of the changing higher education environment. During her doctoral training, Dr. Teruya worked as the Assistant Director of Research and Training for the Building an Intercultural Campus project at Loyola Marymount University and as a research assistant for several projects in the UCLA Department of Education investigating organizational change in public institutions. She has also had administrative, training, and organization development experience as a manager and internal consultant for a large financial institution.

Education and Training

• University of California, Los Angeles, B.A., 1979, Psychology
• University of California, Los Angeles, M.A., 1995, Education
• University of California, Los Angeles, Ph.D., 1999, Education

Contact Info

UCLA Integrated Substance Abuse Programs
1640 S. Sepulveda Blvd., Suite 200
Los Angeles, CA 90025
cteruya@ucla.edu

Selected Publications

• Wilms, W., Teruya, C., & Walpole, M.  (1997).  The clash of accountability and academic freedom.  Change, 29(5), 40-49.
• Teruya, C.  (1999).  Faculty research collaboration:  The invisible model of knowledge production.  Doctoral dissertation, University of California, Los Angeles, Department of Education.
• Hser, Y., Grella, C.E., Collins, C., & Teruya, C.  (2003).  Drug use initiation and conduct disorder among adolescents in drug treatment.  Journal of Adolescence, 26, 331-345.
• Hser, Y., Huang, D., Chou, C., Teruya, C., & Anglin, M.D.  (2003).  Longitudinal patterns of treatment utilization and outcomes among methamphetamine abusers:  A growth curve modeling approach.  Journal of Drug Issues, 33(4), 921-938.
• Hser, Y., Huang, D., Teruya, C., & Anglin, M. D.  (2003).  Gender comparisons of drug abuse treatment outcomes and predictors.  Drug and Alcohol Dependence,72, 255-264.
• Hser, Y., Teruya, C., Evans, E., Longshore, D., Grella, C., & Farabee, D.  (2003).  Treating drug-abusing offenders:  Initial findings from a five-county study on the impact of California’s Proposition 36 on the treatment system and patient outcomes.  Evaluation Review, 27(5), 479-505.
• Hser, Y., Huang, D., Teruya, C., & Anglin, M. D.  (2004).  Diversity of drug abuse treatment utilization patterns and outcomes.  Evaluation and Program Planning,27(3), 309-319.
• Hser, Y., Huang, Y., Teruya, C., & Anglin, M.D.  (2004).  Gender differences in treatment outcomes over a three-year period.  Journal of Drug Issues, 34(2), 415-436.
• Hardy, M., Teruya, C., Longshore, D., & Hser, Y.  (2005).  Initial implementation of California’s Substance Abuse and Crime Prevention Act:  Findings from focus groups in ten counties.  Evaluation and Program Planning, 28, 221-232.
• Grella, C., Hser, Y., Teruya, C., & Evans, E.  (2005).  How can research-based findings be used to improve practice?  Perspectives from participants in a statewide outcomes monitoring study.  Journal of Drug Issues, 35(3), 469-484.
• Teruya, C., Hardy, M., Hser, Y., & Evans, E.  (2006).  Implementation of a statewide outcome monitoring system:  Lessons learned from substance abuse treatment provider staff.  Qualitative Health Research, 16, 337-352.
• Longshore, D., & Teruya, C.  (2006).  Treatment motivation in drug users:  A theory-based analysis.  Drug and Alcohol Dependence, 81, 179-188.
• Hser, Y., Teruya, C., Brown, A. H., Huang, D., Evans, E., & Anglin, M. D.  (2007).  Impact of California’s Proposition 36 on the drug treatment system:  Treatment capacity and displacement.  American Journal of Public Health, 97(1), 104-109.

Top of Page